ArticleJournal of acquired immune deficiency syndromes (1999)2016
Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.
Article in Journal of acquired immune deficiency syndromes (1999), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence.Journal of the International AIDS Society · 2018Pooled it
- Factors associated with the retention of travestis and transgender women living with HIV in a peer navigation intervention in São Paulo, Brazil.Cadernos de saude publica · 2023Trial
- Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.The Journal of infectious diseases · 2020 · on this mapTrial
- Article
- HIV Prevention Research Experiences Among Men Who Have Sex With Men and Transgender Persons of Color.Journal of racial and ethnic health disparities · 2023Article
- Inclusion of Transgender and Gender Diverse People in Phase III Trials: Examples from HIV Pharmacologic Prevention Studies.Clinical pharmacology and therapeutics · 2023Review
- Centering Transgender and Nonbinary Voices in Genital Gender-Affirming Surgery Research Prioritization.JAMA surgery · 2022Article
- Promoting inclusion in clinical trials-a rapid review of the literature and recommendations for action.Trials · 2021Review
- Patient-centered practices for engaging transgender and gender diverse patients in clinical research studies.BMC medical research methodology · 2021Article
- Global scoping review of HIV prevention research with transgender people: Transcending from trans-subsumed to trans-centred research.Journal of the International AIDS Society · 2021Article
- Impact of dedicated women's outreach workers (WOWs) on recruitment of women in ACTG clinical studies.HIV research & clinical practice · 2021Article
- Algorithm to identify transgender and gender nonbinary individuals among people living with HIV performs differently by age and ethnicity.Annals of epidemiology · 2021Article
- Review
- Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State Area.Transgender health · 2020Article
- Article
- HIV prevention and HIV care among transgender and gender diverse youth: design and implementation of a multisite mixed-methods study protocol in the U.S.BMC public health · 2019Article
- The Evolving Role of Pharmacists in Transgender Health Care.Transgender health · 2019Review
- The Importance of Human Immunodeficiency Virus Research for Transgender and Gender-Nonbinary Individuals.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Review
- Characterizing the HIV Prevention and Care Continua in a Sample of Transgender Youth in the U.S.AIDS and behavior · 2017Article
- Facilitators and Barriers to Participation in PrEP HIV Prevention Trials Involving Transgender Male and Female Adolescents and Emerging Adults.AIDS education and prevention : official publication of the International Society for AIDS Education · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
Abstract
In 2009, the National Institutes of Health recognized the need to expand knowledge of lesbian, gay, bisexual, and transgender (LGBT) health and commissioned the Institute of Medicine to report on the health of these populations in the United States. The resulting Institute of Medicine publication called for more knowledge of the health of LGBT populations, as well as improved methodologies to reach them, more LGBT-focused research, and enhanced training programs and cultural competency of physicians and researchers. Several of the National Institutes of Health-funded HIV/AIDS clinical trials networks, including the Adolescent Medicine Trials Network for HIV/AIDS Interventions, HIV Prevention Trials Network, HIV Vaccine Trials Network, and Microbicide Trials Network, have focused attention on engaging transgender (TG) individuals in research. They have identified issues that transcend the nature of research (ie, treatment or prevention, adult or adolescent) and have adopted various approaches to effectively engage the TG community. Each network has recognized the importance of developing partnerships to build trust with and seek input from TG individuals on research plans and policies. They have established standing advisory groups and convened consultations for this purpose. To ensure that trial data are reflective of the participants they are seeking to enroll, they have reviewed and revised data collection forms to incorporate the 2-step method of collecting sex at birth and gender identity as 2 independent variables, and some have also revised research protocol templates and policies for concept development to ensure that they are appropriate for the inclusion of TG participants. The networks have also initiated trainings to enhance cultural sensitivity and developed a range of materials and resources for network and clinical research site staff. They continue to identify TG-specific research needs in an effort to be more responsive to and improve the health of TG individuals, particularly related to HIV/AIDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.